With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
Health
By Rebecca Robbins and Lauren Hirsch from NYT Health https://ift.tt/EHz7O43
via IFTTT Mergers, Acquisitions and Divestitures, United States Politics and Government, Tylenol (Drug), Autism, Suits and Litigation (Civil), Regulation and Deregulation of Industry, Labeling and Labels (Product) The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.

By Rebecca Robbins and Lauren Hirsch from NYT Health https://ift.tt/EHz7O43
via IFTTT Mergers, Acquisitions and Divestitures, United States Politics and Government, Tylenol (Drug), Autism, Suits and Litigation (Civil), Regulation and Deregulation of Industry, Labeling and Labels (Product) The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
Comments
Post a Comment